Scientists
around the world are trying to find a coronavirus vaccine. Who is going to
create this antidote first, there's a competition going on. In some
countries, also, clinical trials have begun. Oxford University researchers are ahead in this challenge though.
Scientists say they are highly confident that next September, the Covid-19
vaccine will reach the market.
Oxford finished the vaccine-making process before others. Oxford University's
generic institute started developing the vaccine in January after the
coronavirus outbreak spread across the globe.
Researchers at Oxford have already developed a
vaccine for a virus similar to Covid-19. It has made them feel confident. "I have a great deal of
confidence in the vaccine," said Sarah Gilbert, a university professor of vaccinology. "Since I've used
its technology before. The coronavirus genetic material has been taken to produce a new vaccine. It was later
viewed as an injection into the common cold virus.
It has been detected that the virus became
inactive. It has lost the ability to spread among people. The modified virus will be set to mimic Covid-19. It
will work to prevent the real Kovid-19 virus. We are hopeful of success in this case."
The Covid-19 vaccine in Oxford was given
experimentally to a group of monkeys. The benefits were revealed. The vaccine was also pushed into the
bodies of 550 volunteers. Oxford scientist Elyssa Granato is amongst the participants. She is
pretty good at that. There was no physical issue. "I was able to do something in the end, a feeling that worked
in me," she said after taking part in the trial.
But yet the effectiveness of the vaccine has not been confirmed. So, next month
in Oxford, the world's largest India based pharmaceutical company will
begin work on millions of vaccines.
